How COVID-19 is changing the future of eye care

The rapid uptake of telehealth services to stop the spread of coronavirus is adding impetus to research to develop innovative new ways of diagnosing and monitoring patients with eye disease.

Normal tension glaucoma: Case study and discussion

Written by Tyson Xu BOptom (Hons) BSc, Specsavers Nowra NSW Tyson graduated from UNSW in 2017 and was the recipient of the Andrew Whatham Centre...

Specsavers Diabetes Action Plan

Early detection and timely treatment can prevent the majority of diabetes-related vision loss. Which is why as a founding partner of KeepSight, Specsavers has...

From inside the test room – the use of OCT

In Australia, macular degeneration is the leading cause of blindness and severe vision loss, with one in seven Australians over 50 having some evidence...

Hot topics in research: Reticular pseudodrusen

15 CPD Minutes in Australia Researchers believe the presence of reticular pseudodrusen may provide valuable insights into a patient’s likely progression to late stage age-related macular degeneration (AMD).

What role does OCT play in diagnosing age-related macular degeneration?

The introduction of OCT as part of a standard eye test for every patient at Specsavers is having an impact on the diagnosis and...

KeepSight – improving health outcomes for patients with diabetes

In 2018, the Australian Government provided funding for a new national diabetes eye screening program, KeepSight, an Australian-first initiative to help in the fight...

The impact of KeepSight on recall rates – two years on

Why focus on recall response rates? Diabetes is the leading cause of blindness in Australia, yet most vision loss can be prevented with regular eye...

Celebrating KeepSight’s two-year anniversary

Hear from some of the KeepSight program’s key players as we celebrate its anniversary. With more than 1.7 million Australians living with diabetes, and...

WATCH: Specsavers Glaucoma Action Plan

Over the past six years, Specsavers has been on a journey to reduce the levels of undiagnosed glaucoma in our patients. This video talks...